- Christopher Burns, President and CEO, Venatorx Pharmaceuticals (US)
- Seamus O’Brien, Research and Development Director, GARDP (Switzerland)
- Kamini Walia, Senior Scientist, Indian Council of Medical Research (India)
Moderator: Jennifer Schneider, Executive Officer, GARDP North America (US)
GARDP was able to make progress in 2020 despite the challenges of the COVID-19 pandemic. This webinar highlighted efforts to advance antibiotic R&D in the midst of the pandemic and underscored the importance of investing in the development of new and improved treatments for drug-resistant infections that pose the greatest threat to health.
This live webinar including interactive Q&A session was broadcast on 29 June 2021.
If you have questions or comments, please let us know: email@example.com.